Models were calculated when (1) adjusting for diabetes duration instead of treatment type, (2) diabetes treatment in four (insulin only; insulin and OHA; OHA; no medication) versus three groups (insulin only or insulin and OHA; OHA; no medication), and (3) controlling for T2DM-DMP enrolment. This evidence concerns the gene INS and type 2 diabetes mellitus.